Skip to content
  • HOME
  • About Us
    • Company Information
      • Vision
      • Greetings
      • Company Infomation
      • About The Company Logo
      • FAQ (About Biozipcode, Inc.)
    • Collaboration with Biozipcode, Inc.
    • Research Members
  • Business
    • Research and Business
      • Development of a Cure for Diabetes
      • Development of a Cure for Diabetes in Pets
      • Advisory
      • Papers and Reviews
    • List of Patents
    • Pipelines
  • News
    • Research
    • Information
  • Contact Us
    • FAQ (Frequently Asked Questions)
    • Contact Us
    • PrivacyPolicy
  • JAPANESE

News

biozipadmin2024-04-23T12:37:29+09:00

Announcement of Capital Increase (Capital: 70 Million Yen)

biozipadmin2024-04-23T12:37:29+09:00April 3, 2024|Information|

biozipadmin2024-06-19T14:19:06+09:00

About the establishment of Biozipcode, Inc.

biozipadmin2024-06-19T14:19:06+09:00December 1, 2023|Information|

biozipadmin2024-01-27T12:07:50+09:00

Visiting Ambassador Hiroi Orikasa at the Embassy of Japan in Palau

biozipadmin2024-01-27T12:07:50+09:00November 17, 2023|Information|

biozipadmin2024-01-27T12:41:53+09:00

A research paper titled “Diabetes can be completely cured” was published in the scientific journal “Communications Biology”

biozipadmin2024-01-27T12:41:53+09:00June 13, 2023|Research|

biozipadmin2024-01-27T11:59:01+09:00

Notice Regarding Changes in Shareholders and Board Members

biozipadmin2024-01-27T11:59:01+09:00January 24, 2023|Information|

biozipadmin2024-01-27T11:50:39+09:00

Announcement of Dr. Hideto Kojima’s Seminar – ‘Saying Goodbye to Diabetes!’

biozipadmin2024-01-27T11:50:39+09:00December 12, 2022|Information|

biozipadmin2024-01-27T11:43:15+09:00

Announcement of Business Collaboration with Co-LABO MAKER, a Venture Company Originating from Tohoku University.

biozipadmin2024-01-27T11:43:15+09:00December 6, 2022|Information|

biozipadmin2024-01-27T11:29:21+09:00

Biozipcode, Inc. exhibited at ‘BioJapan2022’

biozipadmin2024-01-27T11:29:21+09:00September 20, 2022|Information|

biozipadmin2024-01-27T11:27:11+09:00

Announcement of Commencement of Advisory Services for Diabetes and Regenerative Medicine

biozipadmin2024-01-27T11:27:11+09:00September 12, 2022|Research|

biozipadmin2024-01-27T11:12:06+09:00

Announcement of Rights Acquisition Regarding International Patents for Diabetes Treatment

biozipadmin2024-01-27T11:12:06+09:00April 18, 2022|Research|

12Next

Search

Category

  • Information
  • Research

Archive

  • April 2024
  • December 2023
  • November 2023
  • June 2023
  • January 2023
  • December 2022
  • September 2022
  • April 2022
  • January 2022

Biozipcode, Inc.

TEL: +81-50-5534-7865
E-MAIL: info@biozipcode.com

ADDRESS:
〒520-2121
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Biozipcode, Inc.

Shiga University of Medical Science, Department of Regenerative Medicine

Shiga University of Medical Science, Dep. of Regenerative Medicine

Biozipcode, Inc.

We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).

Learn More About Us

Contact Us

Biozipcode, Inc.

TEL:
+81-50-5534-7865

E-MAIL:
info@biozipcode.com

ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121

Contact Us

Languages

JA / JAPANESE

© Copyright 2025 Biozipcode, Inc. All Rights Reserved.

Page load link
Go to Top